| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2020 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 212,337 | $162.92 | $34,593,144.82 | - | |
| Jun 16, 2020 | LNTH Lantheus Holdings, Inc. | Bolla John J. | Chief Operations Officer | Sell | 2,422 | $14.29 | $34,603.11 | -3.9% | |
| Jun 16, 2020 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 17,000 | $162.94 | $2,770,000.00 | -19.7% | |
| Jun 16, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 16,000 | $0.33 | $5,280.00 | - | |
| Jun 15, 2020 | BMY Bristol Myers Squibb Co | Paliwal Dinesh C | Director | Buy | 9,174 | $54.50 | $499,983.00 | +70.9% | |
| Jun 15, 2020 | TLPH Talphera, Inc. | Adams Adrian | Director | Buy | 100,000 | $1.29 | $128,900.00 | +127.0% | |
| Jun 15, 2020 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 7,547 | $1.33 | $10,035.25 | +1.6% | |
| Jun 12, 2020 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 17,232 | $9.33 | $160,809.72 | -0.2% | |
| Jun 12, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 29,000 | $0.31 | $8,991.70 | - | |
| Jun 10, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | Beetham Thomas W. | EVP &Chief Legal Officer | Sell | 13,752 | $25.07 | $344,762.64 | -31.7% | |
| Jun 10, 2020 | IRWD Ironwood Pharmaceuticals Inc | Olanoff Lawrence S | Director | Sell | 11,350 | $10.06 | $114,181.00 | -14.2% | |
| Jun 10, 2020 | CVSI Cv Sciences, Inc. | Mona Michael Joseph Jr | 10% Owner | Sell | 38,803 | $0.80 | $31,042.40 | -6.3% | |
| Jun 9, 2020 | TXMD Therapeuticsmd, Inc. | Finizio Robert G | CEO | Buy | 46,000 | $1.44 | $66,360.00 | +0.1% | |
| Jun 9, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 23,405 | $20.41 | $477,602.43 | -33.7% | |
| Jun 9, 2020 | SNY Sanofi | Sanofi | 10% Owner | Sell | 120,234 | $597.48 | $71,837,410.32 | -30.1% | |
| Jun 9, 2020 | TXMD Therapeuticsmd, Inc. | Collins Cooper C. | Director | Buy | 74,000 | $1.45 | $107,300.00 | +46.7% | |
| Jun 9, 2020 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 21,311 | $9.57 | $203,904.26 | -0.2% | |
| Jun 9, 2020 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 3,075 | $3.81 | $11,706.75 | +0.5% | |
| Jun 8, 2020 | AKBA Akebia Therapeutics, Inc. | Gowen Maxine | Director | Sell | 4,567 | $12.05 | $55,032.35 | -15.9% | |
| Jun 8, 2020 | AKBA Akebia Therapeutics, Inc. | Smith Cynthia | Director | Sell | 4,567 | $12.10 | $55,260.70 | -10.8% | |
| Jun 8, 2020 | AKBA Akebia Therapeutics, Inc. | Gilman Steven C70 | Director | Sell | 4,567 | $12.08 | $55,169.36 | -10.5% | |
| Jun 8, 2020 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 31,425 | $47.31 | $1,486,584.42 | -5.7% | |
| Jun 5, 2020 | BHC Bausch Health Companies Inc. | Valueact Holdings, L.P.73 | Director, See Remarks | Sell | 948,353 | $19.24 | $18,246,311.72 | -100% | |
| Jun 5, 2020 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 10,000 | $150.00 | $1,500,000.00 | -17.7% | |
| Jun 5, 2020 | PCRX Pacira Biosciences, Inc. | Brege Laura62 | Director | Sell | 2,100 | $48.70 | $102,270.00 | -24.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.